MissionIR Articles

  • Tonix Pharmaceuticals Holding (TNXP) Presents at Rodman & Renshaw Conference

    Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is focused on the invention and development of novel pharmaceutical products for medical conditions that it believes have broad societal impact, and that are not well served by currently available…

  • Titan Pharmaceuticals (TTNP) Presents at Rodman & Renshaw Conference

    Titan Pharmaceuticals Inc. (OTCQB: TTNP) is a specialty pharmaceutical company developing proprietary therapeutics primarily for the treatment of serious medical disorders. The company’s lead product candidate, Probuphine®, is a novel and long-acting formulation of buprenorphine…

  • Threshold Pharmaceuticals (THLD) Presents at Rodman & Renshaw Conference

    Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in the microenvironments of most solid tumors as well as the…

  • TG Therapeutics (TGTX) Presents at Rodman & Renshaw Conference

    TG Therapeutics, Inc. (NASDAQ:TGTX) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Currently, the company is developing two therapies targeting hematological malignancies: TG-1101…

  • Tecogen (TGEN) Presents at Rodman & Renshaw Conference

    Tecogen Inc. (NASDAQ: TGEN) manufactures, installs and maintains high-efficiency, ultra-clean combined heat and power products – including natural gas engine-drive cogeneration, air conditioning systems and water heaters for residential, commercial and industrial use. For over…

  • TapImmune (TPIV) Presents at Rodman & Renshaw Conference

    TapImmune Inc. (OTCQB: TPIV) is an immunotherapy company specializing in the development of innovative technologies for the treatment of cancer and infectious diseases. The company’s peptide or nucleic acid-based immunotherapeutics comprise one or more naturally…

  • Stevia First (STVF) Presents at Rodman & Renshaw Conference

    Stevia First Corp. (OTCQB: STVF) is an agricultural biotechnology company enabling the production of dramatically healthier food and nutrition products. The company has developed and is commercializing a novel bioprocessing technique that has the potential…

  • Stemline Therapeutics (STML) Presents at Rodman & Renshaw Conference

    Stemline Therapeutics, Inc. (NASDAQ: STML) is a clinical stage biopharmaceutical company developing novel oncology therapeutics that primarily target cancer stem cells and tumor bulk. The company’s pipeline currently includes two clinical stage product candidates, SL-401…

  • StemCells (STEM) Presents at Rodman & Renshaw Conference

    StemCells, Inc. (NASDAQ: STEM) is currently engaged in the clinical development of its innovative HuCNS-SC® platform technology as a potential treatment for both neurological and retinal disorders. The company’s top-line data from its phase I/II…

  • Stellar Biotechnologies (SBOTF) Presents at Rodman & Renshaw Conference

    Stellar Biotechnologies, Inc. (OTCQB: SBOTF) is the leading manufacturer of sustainable keyhole limpet hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. Through a recently executed strategic collaboration, the company has…

  • SteadyMed (STDY) Presents at Rodman & Renshaw Conference

    SteadyMed Ltd. (NASDAQ: STDY) is a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases with unmet parental delivery needs. The company’s lead drug product candidate, Trevyent®,…

  • Spectrum Pharmaceuticals (SPPI) Presents at Rodman & Renshaw Conference

    Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) is a leading biotechnology company focused on acquiring, developing and commercializing drug products. The company currently markets five hematology/oncology drugs, and it expects an FDA decision on another hematology drug…

  • Sorrento Therapeutics (SRNE) Presents at Rodman & Renshaw Conference

    Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is a clinical-stage biopharmaceutical company developing new treatments for cancer, as well as associated pain, inflammation and immune diseases. The company recently licensed multiple late-stage biosimilar and biobetter antibodies for…

  • Solar3D (SLTD) Presents at Rodman & Renshaw Conference

    Solar3D, Inc. (NASDAQ: SLTD) is a leading provider of solar power solutions focused on the design, installation and management of solar power systems for commercial, agricultural and residential customers. Through its wholly-owned subsidiaries, the company…

  • Social Reality (SCRI) Presents at Rodman & Renshaw Conference

    Social Reality, Inc. (OTCQB: SCRI) is an internet advertising company delivering a complete set of advertising and marketing tools and services powered by real-time automation. The company’s proprietary technology connects the social and digital spheres…

  • Smith Micro Software (SMSI) Presents at Rodman & Renshaw Conference

    Smith Micro Software, Inc. (NASDAQ: SMSI) is a provider of software designed to simplify and enhance the mobile experience. As the leader in wireless connectivity, the company’s applications ensure the best quality of experience for…

  • SITO Mobile (SITO) Presents at Rodman & Renshaw Conference

    SITO Mobile Ltd. (NASDAQ: SITO) provides a mobile engagement platform that enables brands to increase awareness, loyalty and sales. Through its location-based advertising services, the company helps clients drive foot traffic into stores and improve…

  • Signal Genetics (SGNL) Presents at Rodman & Renshaw Conference

    Signal Genetics, Inc. (NASDAQ: SGNL) is a commercial-stage molecular design company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company’s lead…

  • Second Sight Medical Products (EYES) Presents at Rodman & Renshaw Conference

    Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets innovative implantable visual prosthetics that enable blind individuals to achieve greater independence. The company’s lead product is the Argus® II Retinal Prosthesis System, which…

  • Safeguard Scientifics (SFE) Presents at Rodman & Renshaw Conference

    Safeguard Scientifics, Inc. (NYSE: SFE) has a distinguished track record of fostering innovation and building market leaders. For six decades, the company has been providing growth capital and operational support to entrepreneurs across an evolving…